Medical Clinics of North America, volume 107, issue 5, pages 793-805
Atherosclerotic Disease
Amanda M. Morrison
1
,
Alexander E. Sullivan
1
,
Aaron Aday
2
Publication type: Journal Article
Publication date: 2023-09-01
Journal:
Medical Clinics of North America
scimago Q1
SJR: 1.409
CiteScore: 10.2
Impact factor: 3.8
ISSN: 00257125, 15579859
General Medicine
Abstract
Atherosclerotic disease, including stroke and myocardial infarction, is the leading cause of morbidity and mortality worldwide. Atherosclerotic plaque formation occurs in the setting of excess oxidative and hemodynamic stress and is perpetuated by smoking, poor diet, dyslipidemia, hypertension, and diabetes. Plaque may rupture, resulting in acute thrombotic events. Smoking cessation, lifestyle modification, risk factor optimization, and antithrombotic therapies are the mainstays of atherosclerotic disease management and are the cornerstones to reduce morbidity and mortality in this high-risk patient population. Novel therapeutics are in development and will add to the growing armamentarium available to physicians who manage atherosclerotic disease.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.